{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047175","form_type":"8-K","ticker":"CNTN","cik":"0001861657","company_name":"Canton Strategic Holdings, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.148405+00:00","generated_at":"2026-05-29T21:08:16.088607+00:00","sec_items":["5.02","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tharimmune appoints board member, terminates Intract Pharma merger LOI","bullets":["Board increased to six members; Sanam Parikh appointed as director effective November 20, 2024.","Terminated non-binding exclusive Letter of Intent with Intract Pharma Ltd., dated August 19, 2024, effective immediately.","No further details provided on termination reasons or future plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047175","json":"https://secwatch.observer/filing/0001493152-24-047175.json","markdown":"https://secwatch.observer/filing/0001493152-24-047175.md","text":"https://secwatch.observer/filing/0001493152-24-047175.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861657/000149315224047175/0001493152-24-047175-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861657/000149315224047175/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:08:16.088607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}